TI - Could Pretreatment Neutrophil/Lymphosit Ratio and Derived Neutrophil/Lymphosit Ratio Predict Overall Survival of Patients With Extensive Stage Small Cell Lung Cancer?
PT - Journal Article
DP - 2022
TA - EJMI
PG - 33-37
VI - 6
IP - 1
AID - 2022.53326 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2022.53326
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2022 6(1): 33